📰 Avanzanite Bioscience News
Avanzanite Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Avanzanite Bioscience. Real-time updates on events, politics, business and more.
October 18, 2023
AMSTERDAM, October 18, 2023--Avanzanite's expanded collaboration with Advicenne now includes Ireland, Cyprus and Malta in addition to existing markets (DE, AT, CH, GR, LI).
September 11, 2023
51% increase in Sibnayal® gross sales to €0.96 millionSignificant reduction in operating losses to €2.9 million (vs. €4.4 million in H1 2022)€0.9 million improvement in cash flow from operationsCash position of €3.42 millionCompletion of European marketing coverage for Sibnayal®Launch of a capital increase with pref...
February 28, 2023
Advicenne agreement further validates Avanzanite's unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across Europe Avanzanite
February 28, 2023
Advicenne agreement further validates Avanzanite’s unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across EuropeAvanzanite now transitioning to sales execution with the first anticipated commercial launch in Germany mid 2023 AMSTERDAM--(...
January 10, 2023
/PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered in Italy, today announced that it has partnered with Avanzanite Bioscience...
January 10, 2023
SIFI Announces License Agreement With Avanzanite Bioscience for Akantior® - read this article along with other careers information, tips and advice on BioSpace
November 15, 2022
Establishes first-in-class biopharmaceutical commercialization platform specifically addressing rare diseases in Europe Secured exclusive rights in 26 European Countries to an investigational